Susana Jiménez Murcia-rekin lankidetzan egindako argitalpenak (22)

2020

  1. Coronavirus disease 2019 (COVID-19) and obesity. Impact of obesity and its main comorbidities in the evolution of the disease

    European Eating Disorders Review, Vol. 28, Núm. 6, pp. 799-815

  2. Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study

    European Journal of Nutrition, Vol. 59, Núm. 5, pp. 2195-2206

2019

  1. Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making

    Molecular and Cellular Endocrinology, Vol. 497

  2. Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity

    PLoS ONE, Vol. 12, Núm. 2

  2. Brain functional connectivity is modified by a hypocaloric mediterranean diet and physical activity in obese women

    Nutrients, Vol. 9, Núm. 7

  3. Correction: An increase in visceral fat is associated with a decrease in the taste and olfactory capacity (PLoS ONE (2017) 12:2 (e0171204) DOI: 10.1371/journal.pone.0171204)

    PLoS ONE

2016

  1. Decision making impairment: A shared vulnerability in obesity, gambling disorder and substance use disorders?

    PLoS ONE, Vol. 11, Núm. 9

  2. Enduring Changes in Decision Making in Patients with Full Remission from Anorexia Nervosa

    European Eating Disorders Review, Vol. 24, Núm. 6, pp. 523-527

  3. Genetic variations of the bitter taste receptor TAS2R38 are associated with obesity and impact on single immune traits

    Molecular Nutrition and Food Research, Vol. 60, Núm. 7, pp. 1673-1683

  4. Interaction Between Orexin-A and Sleep Quality in Females in Extreme Weight Conditions

    European Eating Disorders Review, Vol. 24, Núm. 6, pp. 510-517

  5. Modulation of irisin and physical activity on executive functions in obesity and morbid obesity

    Scientific Reports, Vol. 6

  6. Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome

    Psychoneuroendocrinology, Vol. 65, pp. 102-108

  7. Smell–taste dysfunctions in extreme weight/eating conditions: analysis of hormonal and psychological interactions

    Endocrine, Vol. 51, Núm. 2, pp. 256-267

2015

  1. Changes in body composition in anorexia nervosa: Predictors of recovery and treatment outcome

    PLoS ONE, Vol. 10, Núm. 11

  2. Circulating betatrophin levels are increased in anorexia and decreased in morbidly obese women

    Journal of Clinical Endocrinology and Metabolism, Vol. 100, Núm. 9, pp. E1188-E1196

  3. Physical activity in anorexia nervosa: How relevant is it to therapy response?

    European Psychiatry, Vol. 30, Núm. 8, pp. 924-931

2014

  1. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index

    International Journal of Endocrinology, Vol. 2014

  2. Moderate-vigorous physical activity across body mass index in females: Moderating effect of endocannabinoids and temperament

    PLoS ONE, Vol. 9, Núm. 8

  3. Relationship between eating styles and temperament in an Anorexia Nervosa, Healthy Control, and Morbid Obesity female sample

    Appetite, Vol. 76, pp. 76-83